Nanobody-targeted photodynamic therapy induces significant tumor regression of trastuzumab-resistant HER2-positive breast cancer, after a single treatment session

M M Deken, MM Kijanka, IB Hernandez, MD Slooter, Riëtte Bruijn, P van Diest, P Henegouwen, C Lowik, Dominic Robinson, AL Vahrmeijer, S Oliveira

Research output: Contribution to journalArticleAcademicpeer-review

47 Citations (Scopus)
48 Downloads (Pure)
Original languageEnglish
Pages (from-to)269-281
Number of pages13
JournalJournal of Controlled Release
Publication statusPublished - 2020

Research programs

  • EMC OR-01-62-02

Cite this